Alira Health and Biocat Announce a Market Access Support Program for 2025

October 30, 2024

Alira Health, a global healthcare advisory and technology company, and Biocat, strategic stakeholder and catalyst for promoting, transforming, and projecting the Catalan life sciences and health innovation ecosystem, are pleased to announce the Market Access Support Program 2025.

This program follows the success of the first two editions of the Startup Support Program offered by Alira Health and Biocat in 2023 and 2024.

The Market Access Support Program 2025 provides advice to selected companies from an expert team to evaluate product maturity and create a market access roadmap. The program offers a 40-hour service package, including:

background analysis.
reimbursement request orientation sessions.
identification of key market access activities.

The Market Access Support Program 2025 is open to medtech, pharma, and biotech companies based in Catalonia that intend to pursue reimbursement/financing for their solution.

Alira Health continues to prioritize assisting life sciences companies, under the umbrella of Biocat, and helping them define an appropriate market access strategy through this program. Our goal is to ensure that these companies understand how to take the right steps at the right time and in the right way to achieve success.”

Chus Castillo Partner, Consulting Iberia, Alira Health

“This program, which we are promoting for the third time together with Alira Health, helps to energize and boost the development of companies in the BioRegion of Catalonia,” highlights Núria Martí, Director of Innovation and Business Development at Biocat.